NCT06413823

Brief Summary

In view of the close interrelationship between the various organs and systems of the body, which cannot be examined in a parceled fashion but rather as an integrated system, this study aims to consider the potential risks associated with cardiovascular disease. By identifying additional, often underestimated, altered functions that may affect the patient's quality of life and interfere with the performance of daily activities, this research study aims to evaluate the patient's functioning in an integrated manner to achieve a holistic view of the health and well-being of the patient and caregiver.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
218

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

May 9, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 14, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 13, 2026

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

2 years

First QC Date

May 9, 2024

Last Update Submit

May 13, 2024

Conditions

Keywords

Cardiovascular diseaseneuropsychologicaldepressionanxietypsychoeducationdysphagiacaregiversleep disordersaltered pneumophonic coordination

Outcome Measures

Primary Outcomes (1)

  • effectiveness of psychoeducation

    The primary outcome variable considered for calculation is the result of the SF-12 (or SF-36) test as a summary index of the effectiveness of psychoeducation.

    24 months

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A minimum of 218 patients recruited from those afferent at the U.O.S.D. Cardiology with NICU P.O. "Piemonte" in Messina will participate in the survey. Statistical power analysis was performed using G\*Power software for a linear regression test, assuming a slope (H1) of 0.2 with a significance level (α) of 0.05 and a power (1 - β) of 0.85. The primary outcome variable considered for the calculation was the result of the SF-12 (or SF-36) test as a summary index of the effectiveness of psychoeducation. The calculation indicated a sample of 218 subjects as adequate for the purpose of detecting the hypothesized effect

You may qualify if:

  • Age between 45 and 85 years;
  • Confirmed diagnosis of cardiovascular disease;
  • Presence of chronic cardiovascular disease;
  • Absence of cognitive impairment or mild/moderate cognitive impairment (Mini Mental Score \>26);
  • Patient who has given informed consent personally or through Legal Representative

You may not qualify if:

  • \- Presence of severe psychiatric and neurological disorders
  • Presence of end-stage oncological disease.
  • Severe visual impairment that cannot be corrected by dioptric lenses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Irccs Centro Neurolesi Bonino Pulejo

Messina, Sicily, 98066, Italy

RECRUITING

Related Publications (1)

  • Cappadona I, Ielo A, Pagano M, Anselmo A, Micali G, Giambo FM, Duca A, D'Aleo P, Costanzo D, Carcione G, Dispenzieri C, Speciale F, Bramanti P, Bramanti A, Garofano M, Corallo F. Observational protocol on neuropsychological disorders in cardiovascular disease for holistic prevention and treatment. Future Cardiol. 2025 May;21(6):349-358. doi: 10.1080/14796678.2025.2483155. Epub 2025 Mar 21.

MeSH Terms

Conditions

Cardiovascular DiseasesDepressionAnxiety DisordersDeglutition DisordersSleep Wake Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Irene Cappadona

    IRCCS Centro Neurolesi Bonino Pulejo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Irene Cappadona, psychologist

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Psychologist

Study Record Dates

First Submitted

May 9, 2024

First Posted

May 14, 2024

Study Start

May 9, 2024

Primary Completion

May 13, 2026

Study Completion

May 13, 2026

Last Updated

May 14, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations